Did not finish prior post - there are very significant positives, most of whuch could move the stock significantly to the upside at any point in time and the stock market is definitely forward looking.

I have no crystal ball, but am very bullish on the molecule.
Unfortunately, it helps the body's immune system fight disease without much in the way of side effects. This very much upsets the apple cart of big pharma's expensive, intrusive and only margially effectve drugs and the FDA regulates them.

The company is looking for a cure and PREP for HIV and treatment for MASH, either of which could move the stock over 10 fold even with stock dilution over the next year - and the knowledgeable seem to think CRC and Alzhiemers have the greatest current potential.

Meanwhile, the board has been taken over by newbie wordsmiths speculating on just how far out the before the gravy train arrives. Real scientists are working with the molecule and are bullish regarding with its potential.